JPRN-UMIN000001434Unknown未知
Clinical trial on efficacy and safety of eradication therapy for Helicobacter pylori infection to prevent gastric cancer. - Helicobacter eradication for gastric cancer prevention.
Department of Gastroenterology University of Tokyo0 sites1,600 target enrollmentStarted: October 20, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Sponsor
- Enrollment
- 1,600
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. gastric malignancies or gastric adenomas 2. gastroduodenal ulcers 3. allergy for medicine used in this study
Investigators
Similar Trials
Completed
Not Applicable
Clinical trial on efficacy of eradication therapy for Helicobacter pylori infection to improve gastric atrophy.Patients of atrophic gastritis with H. pylori infectionJPRN-UMIN000001938Department of Gastroenterology The Tokyo University hospital150
Recruiting
Not Applicable
Clinical trial for the effectiveness and safety evaluation of the plasmaib alone on non-adaptive solid cancer patientsKCT0003422Samsung Medical Center25
Terminated
Not Applicable
Clinical trial to evaluate the safety and efficacy of synthetic bone graft substitutes with growth factors for posterior lumbar interbody fusioKCT0004738The Catholic University of Korea, Seoul St. Mary's Hospital20
Active, not recruiting
Not Applicable
Evaluation the safety and efficacy for gastrocnemius hypertrophy of Botox injectioKCT0008039Asan Medical Center20
Completed
Phase 1
Clinical trial of ShatPlus in SARS-CoV-2 Infection.CTRI/2020/05/025340BVG Life Sciences Ltd BVG Group60